Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Improving Medication Adherence in Post-ACS Patients

This study has been terminated.
(This was a dosing study to determine acceptability. Participants found protocol burdensome and so we terminated.)
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Karina Davidson, Columbia University
ClinicalTrials.gov Identifier:
NCT00576160
First received: December 14, 2007
Last updated: May 13, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)